Nelson N. Stone, MD, discusses longterm data about extended neoadjuvant hormone therapy following radiation therapy for highrisk prostate cancer patients. He observes the morbidity, mortality, and testosterone recovery rates of extended hormone therapy, especially in patients treated with hormone therapy for over 6 months.

Read more here: https://grandroundsinurology.com/long...